All Stories

US biotech Hookipa retracts merger plans with UK company

After announcing acquisition plans at the beginning of 2025, immunotherapeutics biotech Hookipa Pharma has decided not to buy rare disease company Poolbeg Pharma.

Feb 20, 2025 - 19:49
 0
US biotech Hookipa retracts merger plans with UK company
After announcing acquisition plans at the beginning of 2025, immunotherapeutics biotech Hookipa Pharma has decided not to buy rare disease company Poolbeg Pharma.
Read More

Tags:

Previous Article

Pullman Hotels & Resorts Marks South Indian Debut with Pullman Chennai Anna ...

Next Article

'Don't be afraid of change': Penn State Health CFO's advice ...

Related Posts

Illumina board adds activist investor, elevates Scott Gottlieb to chair

Illumina board adds activist investor, elevates Scott G...

Mar 27, 2025  0

Fierce Biotech Fundraising Tracker '25: Glycomine gathers $115M series C; Attovia attracts $90M series C

Fierce Biotech Fundraising Tracker '25: Glycomine gathe...

Apr 16, 2025  0

Biopharmas laid off staffers at least 63 times in Q1: Fierce Biotech analysis

Biopharmas laid off staffers at least 63 times in Q1: F...

Apr 1, 2025  0